CE: Original Research: Creating an Evidence-Based Progression for Clinical Advancement Programs

Kathleen G Burke1, Tonya Johnson, Christine Sites

  • 1Kathleen G. Burke is corporate director of nursing professional development and innovation at the University of Pennsylvania Health System (UPHS), assistant dean of clinical nurse learning and innovation at the University of Pennsylvania School of Nursing, and senior fellow at the Leonard Davis Institute of Health Economics, University of Pennsylvania, all in Philadelphia. Tonya Johnson is associate chief nursing officer at Southcoast Health System, New Bedford, MA; at the time of this study, she was nursing clinical director at the UPHS's Pennsylvania Hospital. Christine Sites is a nursing professional development specialist at the UPHS. Jane Barnsteiner is a professor emerita of pediatric nursing at the University of Pennsylvania School of Nursing, Philadelphia, and editor of translational research and quality improvement at AJN. Contact author: Kathleen G. Burke, kathleen.burke@uphs.upenn.edu. The authors and planners have disclosed no potential conflicts of interest, financial or otherwise.

Summary

This study validated eight nursing competency domains and 186 knowledge, skills, and attitudes (KSAs) for clinical advancement. These competencies provide a framework to enhance nursing practice, accountability, and patient care outcomes.

Related Concept Videos

Guidelines for Writing Outcome01:11

Guidelines for Writing Outcome

When developing expected outcomes for a patient care plan, the nurse should adhere to the following recommendations:
Patient outcomes reflect the patient's response to the goal rather than what the nurse aims to achieve. Terminology should be observable and measurable to avoid the reader's interpretation. The desired outcome should be realistic and achievable in the designated care timeframe. Expected outcomes should align with adjunctive therapies. The outcome should enhance care evaluation by...
Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
Nursing Clinical Information System01:27

Nursing Clinical Information System

Nursing Clinical Information System (NCIS)
A Nursing Clinical Information System (NCIS) is a specialized type of healthcare information system tailored to meet the unique needs of nursing practice. It incorporates the principles of nursing informatics to streamline information management and improve the quality of care delivery.
Critical attributes of NCIS include:
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
Preclinical Development: Overview01:28

Preclinical Development: Overview

Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...